山东药企发威!28个新品收入囊中,11个爆款齐飞涨,2款1类新药掘金10000亿市场

米内网
Jan 05

精彩内容刚结束的2025年,山东新华制药拿下了不俗的成绩单:LXH-1211片获批临床,公司的1类新药矩阵再添猛将;通过自主研发+上市许可持有人变更,公司累计拿下了28个重磅新品,并成功开拓了一个新亚类市场;2025年Q1-Q3在中国三大终端六大市场,公司TOP20产品中有11个爆款销售飞涨。目前,公司的1类新药OAB-14已在II期临床,还有20个新品报产在审,山东新华制药厚积薄发,未来可期。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10